RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Est. Return
18.15%
1 Year Est. Return
+18.15%
AUM
$5.99B
AUM Growth
-$1.53B
(-20%)
Holding
100
Top Buys
| 1 | +$132M | |
| 2 | +$109M | |
| 3 | +$78.3M | |
| 4 |
Geron
GERN
|
+$48.3M |
| 5 |
89bio
ETNB
|
+$41.5M |
Top Sells
| 1 | +$244M | |
| 2 | +$111M | |
| 3 | +$84.6M | |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$82.1M |
| 5 |
Praxis Precision Medicines
PRAX
|
+$58.6M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$12.7B
| $1.6B | 26.76% |
10,281,496
+168,752
|
|
||
2
Vaxcyte
PCVX
$5.5B
| $460M | 7.69% |
12,189,149
+3,499,959
|
|
||
3
Rhythm Pharmaceuticals
RYTM
$7.32B
| $322M | 5.38% |
6,084,412
|
|
||
4
Janux Therapeutics
JANX
$1.61B
| $302M | 5.05% |
11,189,693
+824,041
|
|
||
5
NewAmsterdam Pharma
NAMS
$4.1B
| $208M | 3.47% |
10,138,938
+1,293,938
|
|
||
6
Arcellx
ACLX
$4.82B
| $199M | 3.33% |
3,036,527
+249,200
|
|
||
7
Edgewise Therapeutics
EWTX
$1.59B
| $196M | 3.27% |
8,909,091
|
|
||
8
Avidity Biosciences
RNA
$6.99B
| $186M | 3.11% |
6,300,408
|
|
||
9
Wave Life Sciences
WVE
$1.24B
| $147M | 2.46% |
18,202,009
|
|
||
|
10
89bio
ETNB
$2.19B
| $145M | 2.41% |
19,889,683
+5,714,285
|
|
||
11
ARS Pharmaceuticals
SPRY
$993M
| $137M | 2.28% |
10,860,977
|
|
||
|
SION
12
Sionna Therapeutics
SION
$1.41B
| $109M | 1.82% |
+10,445,322
|
|
||
|
LENZ
13
LENZ Therapeutics
LENZ
$1.16B
| $107M | 1.79% |
4,178,823
|
|
||
14
Dyne Therapeutics
DYN
$2.33B
| $102M | 1.7% |
9,714,392
+3,333,248
|
|
||
15
Tyra Biosciences
TYRA
$773M
| $98.9M | 1.65% |
10,637,290
|
|
||
16
Mineralys Therapeutics
MLYS
$3.38B
| $97.6M | 1.63% |
6,147,280
+1,296,296
|
|
||
|
17
Geron
GERN
$766M
| $96M | 1.6% |
60,379,366
+30,369,830
|
|
||
18
RxSight
RXST
$337M
| $94.5M | 1.58% |
3,743,018
|
|
||
|
BCAX
19
Bicara Therapeutics
BCAX
$997M
| $90.6M | 1.51% |
6,955,993
|
|
||
20
Disc Medicine
IRON
$3.13B
| $78.3M | 1.31% |
+1,577,106
|
|
||
21
GH Research
GHRS
$837M
| $76.6M | 1.28% |
6,944,648
+257,959
|
|
||
22
Apogee Therapeutics
APGE
$3.73B
| $58.6M | 0.98% |
1,569,491
|
|
||
23
Dianthus Therapeutics
DNTH
$1.42B
| $52M | 0.87% |
2,866,733
+1,000,333
|
|
||
24
Zai Lab
ZLAB
$3.15B
| $46.8M | 0.78% |
1,295,040
|
|
||
25
Day One Biopharmaceuticals
DAWN
$738M
| $45.6M | 0.76% |
5,755,577
|
|